<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB"><gtr:id>C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Houlden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802760"><gtr:id>C2C8D77E-CB2F-4FDF-BF53-204159889A5B</gtr:id><gtr:title>The Genetics and Pathophysiology of Spinocerebellar Degeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802760</gtr:grantReference><gtr:abstractText>With an ageing population, spinocerebellar ataxia (SCA) is an increasingly important problem with insidious progression and no specific treatment. The estimated prevalence in adults of non-acquired ataxia in the UK is 10,000 people (data from ataxia UK). This neurodegenerative disorder is selective and progressive causing neuronal loss in the cerebellum which defines the clinical and pathological picture. Genetic factors are known to render cerebellar neurons vulnerable to cell death but a large number of these factors are yet to be identified. In particular the common risk factors and disease modifiers of ataxia are poorly understood.

Using established genomic methods, cerebellar expression techniques, cell culture models and neuropathological investigations we will identify the disease processes and pathways that lead to spinocerebellar degeneration. Understanding these biological processes will help form a network of pathways to investigate environmental causes of ataxia, allow the development of treatments to inhibit or reverse the disease process and precisely characterise patients for clinical trials.</gtr:abstractText><gtr:technicalSummary>Aims
The purpose of this research is to build a genetic framework and establish the functional pathways that lead to spinocerebellar degeneration.

My initial work will identify both the common as well as the rare genetic risk factors and disease modifiers of spinocerebellar ataxia. The effects on expression of these variants will be examined in normal cerebellar, affected lymphoblastoid and brain mRNA. Pathogenic and modifying variants and their interacting proteins will be further investigated with tissue culture and neuropathological approaches.

My current MRC fellowship has been very successful, achieving 4/5 goals with 15 months to go. This has allowed me to develop techniques and establish important collaborations, such as the ataxia DNA and brain bank collection, thus laying the groundwork for future projects. 

Design and methodology
This project incorporates a number of strategies.

1. Investigation of genetic variation in pure spinocerebellar ataxia (SCA) of unknown aetiology and the identification of genetic modifiers of the polyglutamine associated SCAs:

(a) Genome wide association study (GWAS) in pure spinocerebellar ataxia. In a total of 1680 samples, structural changes, copy-number variation and disease associated SNPs will be identified. This will be replicated in a European/USA cohort.

(b) GWAS to identify age-of-onset (AOO) modifiers of SCA1, 2, 3, 6 and 7 in 1255 SCA cases from the UK and EUROSCA. This data will be replicated in Huntington?s disease through the funded Euro-HD-study and we have further access to Japanese/USA/Chinese and Australian SCA cohorts.
 
(c) Deep sequencing for variants in the loci from 1(a) and (b) and for rare coding changes in candidate genes which include known ataxia genes, channel/inositol pathway genes, fly and yeast modifier screen genes.

2. Expression profiling: Many of the variants identified will be non coding and likely to act by altering gene expression. Analysing genome-wide cerebellamRNA expression data will allow the identification of expression differences.

3. Functional investigation: Gene function and protein interactors will be investigated in affected lymphoblastoid/brain mRNA, transient or stable cell models and if a channel-gene is implicated we will collaborate with Hanna/ Schorge to perform channel electrophysiology.
 
4. Neuropathology: This resource has already proven vital to our research in the characterisation of neuropathological features and the investigation of interacting proteins.

Opportunities
A significant proportion of the genetic risk factors will be identified providing a framework of pathways to interrogate functionally. Defining these pathways will facilitate the identification of therapies and allow more effective trials by precise stratification of patient cohorts.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1543359</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European Brain Bank Network</gtr:description><gtr:id>F8AF1955-2F67-477C-B3E6-DA472720C962</gtr:id><gtr:impact>Brain tissue for our research</gtr:impact><gtr:outcomeId>iWsvpuzpkvw-1</gtr:outcomeId><gtr:partnerContribution>Brain tissue for research</gtr:partnerContribution><gtr:piContribution>Brain tissue for our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Partnership for Advanced Computing in Europe (PRACE)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Synaptopathies consortium</gtr:description><gtr:id>9B247633-F539-434E-B76F-0989DD3846B8</gtr:id><gtr:impact>Built up a significant cohort</gtr:impact><gtr:outcomeId>56dda7f8d9c511.31485830-1</gtr:outcomeId><gtr:partnerContribution>Families and samples</gtr:partnerContribution><gtr:piContribution>Synaptopathies consortium: Wellcome Trust strategic award
Sequencing in paroxysmal disorders with collaboration with Rothman, Kullmann, Hanna, Sisodiya, Goadsy and others</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tehran</gtr:collaboratingOrganisation><gtr:country>Iran, Islamic Republic of</gtr:country><gtr:description>University of Tehran</gtr:description><gtr:id>5219899D-2177-48B7-84D2-AA74D48AFC54</gtr:id><gtr:impact>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:impact><gtr:outcomeId>j7X5YhDsm95-1</gtr:outcomeId><gtr:partnerContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:partnerContribution><gtr:piContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC Centre for Neuromuscular Diseases</gtr:description><gtr:id>23023375-4443-4AAF-A266-6F1D7481B896</gtr:id><gtr:impact>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:impact><gtr:outcomeId>5EB6CEB5F9D-1</gtr:outcomeId><gtr:partnerContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:partnerContribution><gtr:piContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sakhalin State University</gtr:collaboratingOrganisation><gtr:country>Russian Federation</gtr:country><gtr:description>Sakhalin Universitycollaboration</gtr:description><gtr:id>F83F5E01-FA7D-41DB-BD97-13AE6A175578</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:outcomeId>GiKwEB27NTk-1</gtr:outcomeId><gtr:piContribution>Collaboration on patients with Neuropathy in Russia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Organization for Rare Disorders (NORD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NORD</gtr:description><gtr:id>2ECBBEE4-038D-456E-989B-3404D8FD0DFC</gtr:id><gtr:impact>Patient's referred and a grant</gtr:impact><gtr:outcomeId>nDa21vfuupd-1</gtr:outcomeId><gtr:partnerContribution>Patient's referred and a grant</gtr:partnerContribution><gtr:piContribution>Patient's referred and a grant</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Brain and Mind Research Institute</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>660192E1-EAF0-44B2-8D46-8A7630FEA56D</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-2</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Athens collaboration on ataxia and neuropathy</gtr:description><gtr:id>3A09FE7E-6B8F-464B-A5EE-B49A624E722A</gtr:id><gtr:impact>Large Greek study on ataxia and neuropathy in Greece</gtr:impact><gtr:outcomeId>GvFsmF4nAKm-1</gtr:outcomeId><gtr:piContribution>Large Greek study on ataxia and neuropathy in Greece</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Neuromics FP7 collaboration</gtr:description><gtr:id>882EC357-ADC2-435B-8EC6-CE05B063C633</gtr:id><gtr:impact>Publications, collaboration and preparation for other rare disease grants</gtr:impact><gtr:outcomeId>56dda6ff4d69f2.22859113-1</gtr:outcomeId><gtr:partnerContribution>Shared results and materials - genome/exome sequencing, functional data and patient materials</gtr:partnerContribution><gtr:piContribution>Neuromics FP7 collaboration where we received funding for a post-doc (to prof hanna) and also funding for sequencing.
There was significant collaboration and added value from this collaboration with shared results and materials</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA</gtr:description><gtr:id>30A89E92-EBC8-495C-BBF3-DDD784A1F16A</gtr:id><gtr:impact>Joint publications and techniques</gtr:impact><gtr:outcomeId>107C332DC25-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on techniques and patients</gtr:partnerContribution><gtr:piContribution>Collaborating on techniques such as developing DNA arrays and exome sequencing in our lab</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wayne State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Wayne State University</gtr:description><gtr:id>8ACB42DA-8182-459B-BD77-4E315AB9BFB9</gtr:id><gtr:impact>Sharing of CMT1A patient data and DNA</gtr:impact><gtr:outcomeId>RpFVHoJATmh-1</gtr:outcomeId><gtr:partnerContribution>Sharing of CMT1A patient data and DNA</gtr:partnerContribution><gtr:piContribution>Sharing of CMT1A patient data and DNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:id>994F7FF7-BCE5-4675-8FA6-B08CB6D4492E</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56ddaab95929e7.94396092-1</gtr:outcomeId><gtr:partnerContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:partnerContribution><gtr:piContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>0EED2C0E-95DD-4F6A-BDE0-32B8B4924EBE</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-3</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC NMC</gtr:description><gtr:id>B82C2BA4-B4EC-4921-A6D6-AB5360085BAD</gtr:id><gtr:impact>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:impact><gtr:outcomeId>e1whaABWaoL-1</gtr:outcomeId><gtr:partnerContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:partnerContribution><gtr:piContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Cambridge collaboration on Dog ataxia and neuropathy.</gtr:description><gtr:id>41DF7E80-9E59-4CFF-A857-21681B09EBDF</gtr:id><gtr:impact>Ongoing work</gtr:impact><gtr:outcomeId>TiLk1mX2EBG-1</gtr:outcomeId><gtr:partnerContribution>Dog tissue</gtr:partnerContribution><gtr:piContribution>Cambridge collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Veterinary Medicine (UPenn)</gtr:department><gtr:description>PENN collaboration on Dog ataxia and neuropathy</gtr:description><gtr:id>623624BE-150B-420B-B449-B84DC5228FD3</gtr:id><gtr:impact>Joint grant submitted to NIH</gtr:impact><gtr:outcomeId>FnkjAQW7K1f-1</gtr:outcomeId><gtr:partnerContribution>Provided tissue and clinical details</gtr:partnerContribution><gtr:piContribution>PENN collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>CB9B39E4-6DAE-4495-9D6A-D7EAB66FE6BD</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-1</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sarah Matheson Trust for MSA</gtr:description><gtr:id>C8DFA3C0-4B3E-42E5-BABD-E363BD316A4D</gtr:id><gtr:impact>Publications, Brought patients and encouraged brain donation of MSA patients for our research</gtr:impact><gtr:outcomeId>921118C1E24-1</gtr:outcomeId><gtr:partnerContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:partnerContribution><gtr:piContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ataxia UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ataxia UK</gtr:description><gtr:id>BD5DF1FC-272A-4266-8C31-341B6E807F32</gtr:id><gtr:impact>Publications, made UK patients with Ataxia more aware</gtr:impact><gtr:outcomeId>A7FFBA7590F-1</gtr:outcomeId><gtr:partnerContribution>Made members aware of our work, identified patients and families</gtr:partnerContribution><gtr:piContribution>Information and genetic analysis of patients</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Thessaly</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Thessaly</gtr:department><gtr:description>Larisa Greek parkinsonism study</gtr:description><gtr:id>24BE1683-DEBD-42CA-91A3-7C6B3799FDAE</gtr:id><gtr:impact>Over 1200 Greek parkinsonian patients and controls collected and DNA extracted.

Work ongoing, GWAS underway</gtr:impact><gtr:outcomeId>hSTdgtcyGvw-1</gtr:outcomeId><gtr:piContribution>Larisa Greek parkinsonism study.

Over 1200 Greek parkinsonian patients and controls collected and DNA extracted</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanford Heart Hospital</gtr:collaboratingOrganisation><gtr:description>dystonia genetics and functional gene collaboration</gtr:description><gtr:id>9AD191A6-774C-4AC1-9BC2-CD8BC5334811</gtr:id><gtr:impact>DMRF joint grant</gtr:impact><gtr:outcomeId>JHUxh8CKWJY-1</gtr:outcomeId><gtr:partnerContribution>dystonia genetics and functional gene collaboration</gtr:partnerContribution><gtr:piContribution>Exome sequencing, fibroblast and expression studies</gtr:piContribution><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa</gtr:description><gtr:id>8A6AEE66-F394-4A3C-A898-7A10B1377758</gtr:id><gtr:impact>Sharing of families and data</gtr:impact><gtr:outcomeId>5463d47cdc4257.17558439-1</gtr:outcomeId><gtr:partnerContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:partnerContribution><gtr:piContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>British Medical Association (BMA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BMA</gtr:description><gtr:id>6DB98E30-3485-45EA-BA57-4F63EC8872D4</gtr:id><gtr:impact>Funding and publication</gtr:impact><gtr:outcomeId>nrTBYatScPi-1</gtr:outcomeId><gtr:partnerContribution>Funding and good press for our research</gtr:partnerContribution><gtr:piContribution>Funding and publication</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>2C654026-413F-4AC0-B37E-22123B135F4D</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-2</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>EC FP6 Collaborative Projects</gtr:department><gtr:description>EUROSCA</gtr:description><gtr:id>461A1D36-5ECB-48D9-902D-C06A5025D13F</gtr:id><gtr:impact>Publications as already give. Patients and clinical details of cases with ataxia</gtr:impact><gtr:outcomeId>C8022CF03BB-1</gtr:outcomeId><gtr:partnerContribution>EUROSCA is a collaboration between researchers and clinicians working on ataxia. These has brought cases and techniques that have benefited my research.</gtr:partnerContribution><gtr:piContribution>Identification, screening and functional characterization of ataxia genes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MSA Trust</gtr:description><gtr:id>62B03FA0-80AD-4825-9B4C-C2590CD0E8F9</gtr:id><gtr:impact>Publications, data, tours of the lab, newsletter information</gtr:impact><gtr:outcomeId>eodK9WGCHrW-1</gtr:outcomeId><gtr:partnerContribution>Patients, we write a research update in the newletter, many patients have given blood and donated their brain as a result of the research</gtr:partnerContribution><gtr:piContribution>Data, tours of the lab, newsletter information</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neuromics</gtr:department><gtr:description>Neuromics neurogenetics collaboration</gtr:description><gtr:id>0A646E16-4DAB-45C4-B9E0-783E5FE80DC5</gtr:id><gtr:impact>Recently started</gtr:impact><gtr:outcomeId>ncvkmb8CSLy-1</gtr:outcomeId><gtr:partnerContribution>Groups working on several areas of genetics</gtr:partnerContribution><gtr:piContribution>We are the channelopathy and ataxia part of the collaboration. Our role is exome sequencing, genetics and expression</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>A166E39E-5F10-4D8F-9DAA-C257C18F35E4</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-1</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European and American Brain Bank Network</gtr:description><gtr:id>2FAE6BBF-1C5C-43EC-B1EC-7D00C8E45698</gtr:id><gtr:impact>Publications and the addition of important tissue resources</gtr:impact><gtr:outcomeId>76D7752909A-1</gtr:outcomeId><gtr:partnerContribution>Collaborated with tissus</gtr:partnerContribution><gtr:piContribution>This collaboration has given valuable patient brain tissue to our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Childhood Motor Neuron Disease or BVVL society</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FBE69C7A-1204-4DC8-AF6E-175EF83D7388</gtr:id><gtr:impact>BVVL expert panel

Many patients referred for further investigation and have given tissue and blood</gtr:impact><gtr:outcomeId>f1fzthTFJT3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MSA society</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>868B5212-A2D6-43F8-8350-970D74941414</gtr:id><gtr:impact>Newsletter to 1-2000 people in the UK.
We do this 2-3 times a year with photgraphs and updates.
We do a yearly lab tour to the socity and patients.

Many new patients, DNA, great interest in the brain bank. Patients have done a number of sponsored things for this research</gtr:impact><gtr:outcomeId>oLsjXhPAS1n</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CD295B5F-4FE7-437F-AC9C-82166FBAB716</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56dda9db80bbe3.87510799</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Spastic paraplegia society booklet</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>19B09811-8C69-4754-9D36-A5C35ECD6794</gtr:id><gtr:impact>HSP society, 2000-3000 patients. designed a management booklet.

Better care for patients</gtr:impact><gtr:outcomeId>iLsSGoPpLVD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Neuromuscular research day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2163A2F1-9532-4F20-8A60-F0771C4F2119</gtr:id><gtr:impact>Around 100 patients

More patients involved in our research</gtr:impact><gtr:outcomeId>X2LAP1Nu5SH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Backmann-Strauss dystonia society meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AE40C1AC-47FC-4ACB-877A-2378344B2DAB</gtr:id><gtr:impact>Backmann-Strauss dystonia society meeting and presentation</gtr:impact><gtr:outcomeId>iHwpJCexv4C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HSP society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B7A6559-479B-43FD-9AE3-9CDF8F213698</gtr:id><gtr:impact>HSP yearly meet and section in HSP booklet</gtr:impact><gtr:outcomeId>k9hnMBBF1Tf</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>21000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BMA project grant</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>British Medical Association (BMA)</gtr:fundingOrg><gtr:id>CCFD24F1-43D2-42E2-8F8E-936844D4DDE5</gtr:id><gtr:outcomeId>XzmCihY2FME0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>339000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCL CBRC equipment grant</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A49EB39F-FA0D-49B2-AD00-437A329A644A</gtr:id><gtr:outcomeId>dUpcMETjjAq0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>522000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D68C989B-511B-4339-B2B2-5757432684E6</gtr:id><gtr:outcomeId>WY8wrgqyU5T0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>980000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef> The Wellcome Trust (equipment and the Synaptopathies strategic award (104033/z/14/z)</gtr:fundingRef><gtr:id>62620912-B1F4-487C-B0D1-A516FC7A3709</gtr:id><gtr:outcomeId>56dda8c7bbcb17.45050507</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equipment Grant</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F0CAAF67-FAA9-4FE0-89AD-44C9DEF3E7B1</gtr:id><gtr:outcomeId>egr99fv6iyH0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (The Pathophysiology of Spinocerebellar degeneration)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5ED3EF2E-D7DE-4BBA-B7B7-8D5BF13C7574</gtr:id><gtr:outcomeId>B030D9EC4A50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment award Wellcome Trust</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B87F3C6B-88AF-487C-B4D5-F91C211F49A1</gtr:id><gtr:outcomeId>fUgJjWPHDak</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>98000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>CRBC project grant/CRBC</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4AD09B2F-DBA3-418A-AD18-81B2A7E672D8</gtr:id><gtr:outcomeId>TmtgEopjWs60</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Improved and larger range of neurogenetic tests</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B3E1741-211A-41C8-8A66-F3D09175A552</gtr:id><gtr:impact>Improved and larger range of neurogenetic tests. This leads to greater research and a better service for patients</gtr:impact><gtr:outcomeId>19BADAC486D</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Development of gene panel testing in neurological disorders. This covers each clinical group of neurological disorders and will be available from January 2013 through the NHS and other outside groups at a cost basis</gtr:description><gtr:id>CB74BB8C-8450-4313-A771-E801467010CB</gtr:id><gtr:impact>Development of gene panel testing in neurological disorders. This covers each clinical group of neurological disorders and will be available from January 2013 through the NHS and other outside groups at a cost basis
Impacts:
1. Many more genes offered, using panels these genes are completely covered.
2. Cheaper testing
3. Faster turnaround</gtr:impact><gtr:outcomeId>qGHGwPZVLrG</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Development of gene panel testing in neurological disorders</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>he discovery of two genes for Childhood MND have changed practice and patients are now treated with Riboflavin and new genetic tests</gtr:description><gtr:id>B0B0B608-A01F-40D2-AE11-8F75166357E0</gtr:id><gtr:impact>he discovery of two genes for Childhood MND have changed practice and patients are now treated with Riboflavin</gtr:impact><gtr:outcomeId>Sqcq3mUJr7e</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Riboflavin in MND and new gene tests</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>6DB45F02-C61E-4D1E-B2E0-1579B1BEAADC</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb2d8515fe7.79983577</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Genome sequencing and GeCIP</gtr:description><gtr:id>534152FF-1711-4B3B-BF9C-A369E2BA22A6</gtr:id><gtr:impact>Genome sequencing and GeCIP</gtr:impact><gtr:outcomeId>56ddb25982b527.74911307</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genome sequencing and GeCIP</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>AC52EF33-0B62-4A0A-A4E1-6A9FA11C610A</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb28f1d6eb5.21354160</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Muscle international registry and biobank</gtr:description><gtr:id>B21EA6D4-9F7B-4EB0-8015-C68B58C2E5AD</gtr:id><gtr:impact>Muscle international registry and biobank</gtr:impact><gtr:outcomeId>edKKnP7UcCJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Muscle international registry and biobank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BFB22E0D-44AC-4BEE-9F1E-CF51BCF59630</gtr:id><gtr:title>THAP1 mutations in a Greek primary blepharospasm series.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>pm_15519_29_23036512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A696310F-B269-44B4-BFAE-69A0B7D157DF</gtr:id><gtr:title>Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4721812e6d535c3d1145e4ec8237e968"><gtr:id>4721812e6d535c3d1145e4ec8237e968</gtr:id><gtr:otherNames>Hufnagel RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>56a4096e17bf55.05066889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB47E64E-402F-4AD4-BC77-42D09C1F0A78</gtr:id><gtr:title>MFN2 deletion of exons 7 and 8: founder mutation in the UK population.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/230c6ae6cfa4b1a456b4b475e336d4da"><gtr:id>230c6ae6cfa4b1a456b4b475e336d4da</gtr:id><gtr:otherNames>Carr AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>56a4096b7b6925.90339107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA87E84C-6AE8-40FE-8651-6A773591C27C</gtr:id><gtr:title>Cerebral small vessel disease-related protease HtrA1 processes latent TGF-? binding protein 1 and facilitates TGF-? signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/128b97c9a0949e6460aade7db5f751eb"><gtr:id>128b97c9a0949e6460aade7db5f751eb</gtr:id><gtr:otherNames>Beaufort N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54629744bb0a73.11225902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7994F6E-C741-4FA8-8C2D-49B20F411194</gtr:id><gtr:title>C19orf12 mutation leads to a pallido-pyramidal syndrome.</gtr:title><gtr:parentPublicationTitle>Gene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1119</gtr:issn><gtr:outcomeId>54629741038135.22563328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D48BA1F-24FA-418E-88E4-057171D734DB</gtr:id><gtr:title>Clinical implications of genetic advances in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_15519_29_24018473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B0F78AF-69D6-4021-BBB5-8A9522C2886D</gtr:id><gtr:title>Next-generation sequencing in neuromuscular diseases.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af3d01a303955ec87d9796b29ee01eb6"><gtr:id>af3d01a303955ec87d9796b29ee01eb6</gtr:id><gtr:otherNames>Efthymiou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>58c7eec7f02423.19690192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EC1813E-28B5-4A1E-A530-C6458ADE908B</gtr:id><gtr:title>DNA repair in the trinucleotide repeat disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c7eec6304fc1.35669103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8B226C7-63FA-49E5-B12F-642326689F9D</gtr:id><gtr:title>Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cbecc303d2e334d5905d7f14159341e"><gtr:id>7cbecc303d2e334d5905d7f14159341e</gtr:id><gtr:otherNames>Madeo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec54697a0.91691733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A22443C7-5350-4967-9195-A00829632D57</gtr:id><gtr:title>Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e168e1680c0b01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>472BD0F4-2D5B-4CF0-BD5B-CB9F265FA96F</gtr:id><gtr:title>Genetic linkage analysis of a large family with photoparoxysmal response.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4bfae792d5ae9491325012d23555157"><gtr:id>e4bfae792d5ae9491325012d23555157</gtr:id><gtr:otherNames>Lo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>rqxRz3qeX5X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3700FB4-26F1-4CC8-961E-E04E73FFB474</gtr:id><gtr:title>A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76e00af3054632a7f1e9c1cff9e43c54"><gtr:id>76e00af3054632a7f1e9c1cff9e43c54</gtr:id><gtr:otherNames>Carvalho OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>sFBe5gXzu2w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8CA1962-2305-43C1-8F7E-DC41E0FB610E</gtr:id><gtr:title>Genetic and clinical characteristics of-related Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa93ee933f687.43989614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7736826-94F3-4028-B770-8EEBF2A6489E</gtr:id><gtr:title>The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15519_29_22689585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2AD2C85-5A8E-4E2F-8FF7-19C7B9D8C56B</gtr:id><gtr:title>Spinocerebellar ataxia type 11.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2df3bc2ec28ba7b9d1138e19fcb25ea"><gtr:id>b2df3bc2ec28ba7b9d1138e19fcb25ea</gtr:id><gtr:otherNames>Giunti P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>sNQHseaGAfv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3697340-9954-4249-B800-179AFEC04773</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58c7eec8c24b74.65858354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A733F0D-7ABF-48D4-864F-F0F73DD8306A</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_15519_29_23292638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99167CE0-F9BF-42C0-B5B4-6F7D3F9FFE35</gtr:id><gtr:title>Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>546297423a3570.64051165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDAFB0D3-7099-431D-86EC-C58B6B5845B2</gtr:id><gtr:title>Defective N-linked protein glycosylation pathway in congenital myasthenic syndromes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23436500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A232C17-DCE9-41B9-AE93-274487433951</gtr:id><gtr:title>Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_15519_29_23649896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>612A7780-0D80-434A-80CA-C4DA625F2A14</gtr:id><gtr:title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_15519_29_22406228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A6B4DE3-2548-4705-9438-4E947094C24B</gtr:id><gtr:title>Analysis of the prion protein gene in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec697bc97.94691774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0F5D829-A668-4D26-9CC6-EF74F4AC67E5</gtr:id><gtr:title>Mutational analysis of parkin and PINK1 in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd67cee39ecc846d62acf37d23c82716"><gtr:id>bd67cee39ecc846d62acf37d23c82716</gtr:id><gtr:otherNames>Brooks JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_20034704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB8F07BB-414F-4995-8C46-3AD41627AF8C</gtr:id><gtr:title>Neuroimaging features of neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_15519_29_21920862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D3D3127-42F3-43A3-8B5C-D1974CBC14F3</gtr:id><gtr:title>Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ea971f41f8b71d54e54576d18e6ea4"><gtr:id>c2ea971f41f8b71d54e54576d18e6ea4</gtr:id><gtr:otherNames>Lee HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_15519_29_22543779</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04DC2CA7-F712-4FF7-A13F-394E221D5F3F</gtr:id><gtr:title>H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56a4096c710168.69605258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62315BF2-0B59-4D1F-A7F7-FA22F85DC9EE</gtr:id><gtr:title>Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54629741bd8da2.69740288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6F390EA-41E2-4912-AAB0-9595A3A0E37C</gtr:id><gtr:title>The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f95aa813f473ac4f55c06f44414f70d4"><gtr:id>f95aa813f473ac4f55c06f44414f70d4</gtr:id><gtr:otherNames>Duran R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23225227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA397B05-5914-44BC-B340-FBAD2A8919D5</gtr:id><gtr:title>Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_24198383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36414A83-A38A-4C7F-8AF5-4E87FD140BAC</gtr:id><gtr:title>Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096d9d8c15.84685086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BF219A4-CEE0-495A-82F9-BD48F23B35F0</gtr:id><gtr:title>Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22488887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A22299F-DD88-4D24-BC30-E5C0D6DC3D8C</gtr:id><gtr:title>Multiple system atrophy and repeat expansions in C9orf72.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>54629744015a89.26798603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5333EC2F-9E4F-4880-9375-1106B49FBCA8</gtr:id><gtr:title>What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b03cc72ff363e8c8ae86303a127f41b"><gtr:id>4b03cc72ff363e8c8ae86303a127f41b</gtr:id><gtr:otherNames>Karaszewski B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a40968763867.14464972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>423AD3E9-8964-4C83-9E01-C452D21392A0</gtr:id><gtr:title>Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c42c663e0f22036e78de1c30a1c181"><gtr:id>86c42c663e0f22036e78de1c30a1c181</gtr:id><gtr:otherNames>Rebelo AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec5b50ae0.52037791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02CC31E8-E314-4AB1-8762-FCFD0CDB7B17</gtr:id><gtr:title>Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15519_29_22845787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2418F14A-5E1B-4084-9F7D-11EF8E8017A1</gtr:id><gtr:title>Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdebfc3106d26158fd0e21d9e4ce5d03"><gtr:id>cdebfc3106d26158fd0e21d9e4ce5d03</gtr:id><gtr:otherNames>Cleeter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>Cnf12eK7rMm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E2FFBA-5FF1-4D77-B291-100C7DEE4360</gtr:id><gtr:title>Young-onset parkinsonism due to homozygous duplication of a-synuclein in a consanguineous family.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a710ca1824f44073ef7bb8d23ab87321"><gtr:id>a710ca1824f44073ef7bb8d23ab87321</gtr:id><gtr:otherNames>Kojovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23283657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F41B2A86-9EA1-4571-9D82-9474C5AD8FDD</gtr:id><gtr:title>Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5462974073c8c0.14968936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>427FB520-7E88-4BE1-BB06-1250D6080F83</gtr:id><gtr:title>NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_15519_29_23746447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6055223-644C-4205-ADC1-84E6C940CE89</gtr:id><gtr:title>Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54629743c60ff1.26431156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C5C345A-83A2-472E-BE74-296CB884BF66</gtr:id><gtr:title>ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94931914f1fe9277fbe2bc12b6a4c8a0"><gtr:id>94931914f1fe9277fbe2bc12b6a4c8a0</gtr:id><gtr:otherNames>Schneider SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>iBVEboonxJL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54025A4-90EF-4AFB-A8A2-92E6EC23159F</gtr:id><gtr:title>Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58c7eec71d4765.83547065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02D8863B-5BF3-47A5-91AD-182DECF46D15</gtr:id><gtr:title>Genetic variability at the PARK16 locus.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>diiiL26RA7R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66E8F520-EE8B-4DF7-A1E2-1AB4C757DAEF</gtr:id><gtr:title>DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec983ff40.65236389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FBAA86F-EEB5-4EEC-8110-FD3C2197BB9F</gtr:id><gtr:title>Parkinson's disease induced pluripotent stem cells with triplication of the a-synuclein locus.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b016b620411b3da51cfd468ebe3c2a"><gtr:id>81b016b620411b3da51cfd468ebe3c2a</gtr:id><gtr:otherNames>Devine MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>c9Zqxp6snpK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F84BE0E-5FF4-421C-8109-7B7DB1D7B722</gtr:id><gtr:title>Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling.</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7fccc55a62cf97212e1cfed26905242"><gtr:id>f7fccc55a62cf97212e1cfed26905242</gtr:id><gtr:otherNames>Schorge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>T7khqofiwP7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7D4BB8D-DCF1-4747-BA21-378E70E2C900</gtr:id><gtr:title>Mutations in the autoregulatory domain of ?-tubulin 4a cause hereditary dystonia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23424103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B594DBFD-4256-4264-82FB-772EB4E190E4</gtr:id><gtr:title>A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a0840fa64698c2bea936eb7c3ca6bc7"><gtr:id>1a0840fa64698c2bea936eb7c3ca6bc7</gtr:id><gtr:otherNames>Gami P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56a40967b7bf46.28979690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B33A0314-4CFA-4CA6-988F-0BBBE723AE5E</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297449961a7.86208688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89F44BC9-667B-48FC-9383-6CCB1CBDC257</gtr:id><gtr:title>THAP1 mutations (DYT6) are an additional cause of early-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>h71GPDwA7nJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>695DD501-4176-400C-A7A6-8B3CF3C53DE4</gtr:id><gtr:title>Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>CDnspG8uJ52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C9D409C-895B-4D8C-A74C-1716F59DE871</gtr:id><gtr:title>DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c2f965aac424ae82975cc69a19e1f8"><gtr:id>76c2f965aac424ae82975cc69a19e1f8</gtr:id><gtr:otherNames>Nacheva E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa93ee8d92817.72281319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25312BBB-CF64-4C36-AF52-02B0EC222A54</gtr:id><gtr:title>A novel a-synuclein missense mutation in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23427326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F623EA24-714D-4488-AD25-B25D4ECE8E91</gtr:id><gtr:title>MSA-C or SCA 17? A clinicopathological case update.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f07a33be90f6f19bd438059328a9dbb8"><gtr:id>f07a33be90f6f19bd438059328a9dbb8</gtr:id><gtr:otherNames>Doherty KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4a906b1.58904398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2244D952-6524-45B7-B537-CB1BEE132795</gtr:id><gtr:title>Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>54629744516a73.55359918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DEC68F7-A205-4310-B2EC-4050D03E0AFB</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1657502-8EA0-415B-930B-0A82EE373A84</gtr:id><gtr:title>Kohlsch&amp;uuml;tter-T&amp;ouml;nz syndrome: mutations in ROGDI and evidence of genetic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15519_29_23086778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E8EEB17-B8E6-44BF-A87A-5C606A0748BD</gtr:id><gtr:title>Multiple system atrophy: the application of genetics in understanding etiology.</gtr:title><gtr:parentPublicationTitle>Clinical autonomic research : official journal of the Clinical Autonomic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-9851</gtr:issn><gtr:outcomeId>56a4096de2d5a4.27156370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC632FB-29DA-48D5-B312-9F853CD3615F</gtr:id><gtr:title>c-Jun expression in human neuropathies: a pilot study.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6439b399512804b313ce7684f719df42"><gtr:id>6439b399512804b313ce7684f719df42</gtr:id><gtr:otherNames>Hutton EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22176144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99EAB18-F746-4C8B-8CC8-7E06820A9319</gtr:id><gtr:title>Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8fab38dd5065abc5a928948b76aff2f"><gtr:id>d8fab38dd5065abc5a928948b76aff2f</gtr:id><gtr:otherNames>Pais?n-Ruiz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>arBrMzo5xR3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57910F8D-D319-4E7E-9BA8-808A01715904</gtr:id><gtr:title>Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5aa93ee97e6360.05809732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4325A196-B36A-4FB2-92DF-000808BC8A06</gtr:id><gtr:title>Mutations in noncoding regions ofare a major cause of X-linked CMT.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32eced6165160ce76ae4eaa88f46e3d0"><gtr:id>32eced6165160ce76ae4eaa88f46e3d0</gtr:id><gtr:otherNames>Tomaselli PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec22d5770.85222790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E25AA3C2-4871-4A92-9FAB-A7D4A4AF4A00</gtr:id><gtr:title>The frequency of spinocerebellar ataxia type 23 in a UK population.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c4d0dfc03600335329f8ac761e66b0"><gtr:id>41c4d0dfc03600335329f8ac761e66b0</gtr:id><gtr:otherNames>Fawcett K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23108490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D33E76F-9C45-4AA3-B85F-FAD385D330C5</gtr:id><gtr:title>Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a4096c135da9.29522020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C6B7674-018C-4187-9B2D-CB52CC78053C</gtr:id><gtr:title>Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0a851b1e66126a42944d2b038e10b89"><gtr:id>f0a851b1e66126a42944d2b038e10b89</gtr:id><gtr:otherNames>Baets J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096cd137c6.92269926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09626F90-CEF0-4566-A017-9C8BFDD5BEA3</gtr:id><gtr:title>Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d07df80fc290c1d52c3bc40ece361da1"><gtr:id>d07df80fc290c1d52c3bc40ece361da1</gtr:id><gtr:otherNames>Pappas SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56a4096ba95413.70240517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05E86458-64FF-45E5-B3ED-7EEE7CB591F5</gtr:id><gtr:title>Alpha-synuclein mRNA expression in oligodendrocytes in MSA.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a25a6988d5aadc65741d1b68af379f6"><gtr:id>1a25a6988d5aadc65741d1b68af379f6</gtr:id><gtr:otherNames>Asi YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>54629741e1f2d4.25980501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AE5B915-BFFD-4CB7-BD4E-F57CC9A8E470</gtr:id><gtr:title>CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec8527fc2.35446189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>954C12C8-65D8-45CD-A32C-87DF9F07B268</gtr:id><gtr:title>X inactivation in females with X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_15519_29_22483671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0C3DDCF-952F-437A-92C9-7E881BFB5947</gtr:id><gtr:title>A Huntington's disease phenocopy characterized by pallido-nigro-luysian degeneration with brain iron accumulation and p62-positive glial inclusions.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699401602f933276abda64770fc6df19"><gtr:id>699401602f933276abda64770fc6df19</gtr:id><gtr:otherNames>Ahmed Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>i1shXyLqm5j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>229396F4-3332-488C-894D-FE79AD23C2C0</gtr:id><gtr:title>Mutation in FAM134B causing severe hereditary sensory neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_21115472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE97F413-4487-4B07-AD32-394D910602DE</gtr:id><gtr:title>Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical Signatures.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8655b80f35da06543063892dc80fc48b"><gtr:id>8655b80f35da06543063892dc80fc48b</gtr:id><gtr:otherNames>Brady S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>58c7eec6e64d01.00619670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37384C81-7C84-4592-B453-FCCE3C66370E</gtr:id><gtr:title>Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22382358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89555A84-7D60-45C0-9DE0-2FFC6767E724</gtr:id><gtr:title>Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22577229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6BFBF94-A3F2-49FC-913D-C3BF61D38B03</gtr:id><gtr:title>THAP1 mutations and dystonia phenotypes: genotype phenotype correlations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22903657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85509C14-5395-452D-9023-08151CCD2C76</gtr:id><gtr:title>Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56a4096d352552.37092377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55A8F8C4-5AB8-4363-AB9F-7F8A57E0A9D8</gtr:id><gtr:title>Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23658386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3F400D3-A3DE-4F50-A570-C36D2CFC3FB5</gtr:id><gtr:title>Heterogeneity in clinical features and disease severity in ataxia-associated SYNE1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec516ddb9.24620014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86D85EF4-4C97-4B0C-A4D5-F04193541D3B</gtr:id><gtr:title>Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15519_29_23363396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19FB3296-627F-4846-8DD9-769387F966E9</gtr:id><gtr:title>Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23674490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAC651FD-7CE1-460F-9E7A-F698A334D007</gtr:id><gtr:title>SPG11 Presenting with Tremor.</gtr:title><gtr:parentPublicationTitle>Tremor and other hyperkinetic movements (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94931914f1fe9277fbe2bc12b6a4c8a0"><gtr:id>94931914f1fe9277fbe2bc12b6a4c8a0</gtr:id><gtr:otherNames>Schneider SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2160-8288</gtr:issn><gtr:outcomeId>pm_15519_29_23439843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C823D8C-9BD6-4BB1-8298-0C6F4861E892</gtr:id><gtr:title>Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c8c7cefbd596fac1d4f5555aa91ee"><gtr:id>159c8c7cefbd596fac1d4f5555aa91ee</gtr:id><gtr:otherNames>Jaffer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40967eb2611.14469790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09F9F887-B70E-4E4B-8DE1-1461209BB3B0</gtr:id><gtr:title>Syndromic associations and RNF216 mutations.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966e735d9.20805480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>896C47B8-B692-40C7-98C8-AD5B1F2ACFEC</gtr:id><gtr:title>A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec7bd0174.61165546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F367651-20A5-4815-8DE8-90F729C98B62</gtr:id><gtr:title>De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eeca21b045.36026166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>315C55FE-A22C-46C6-BAE2-D0DAE8B037B4</gtr:id><gtr:title>Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80583ad27ad24e91c0380658e597d61a"><gtr:id>80583ad27ad24e91c0380658e597d61a</gtr:id><gtr:otherNames>Gonzalez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_23729695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F064260-4959-46ED-A58D-88F0D40B4CD9</gtr:id><gtr:title>Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c12954aa30a8fba72f3439d776bda00b"><gtr:id>c12954aa30a8fba72f3439d776bda00b</gtr:id><gtr:otherNames>Salpietro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec25ec5b2.59299037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04D17675-5376-4ECA-83CA-C41DFCA20CB8</gtr:id><gtr:title>Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>54629740424d32.72626144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C48DC5FE-701D-4081-AD25-EC5E9E7BE24D</gtr:id><gtr:title>Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_15519_29_22520093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66C1662E-C2EE-4BEC-830E-72171C2891EA</gtr:id><gtr:title>Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a4096e53c528.99196298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>769C9261-F15A-4091-9FC3-C4BB99A8CA9C</gtr:id><gtr:title>Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>iqjnSQ1tBnv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6F41823-0D9C-43C2-9DDB-4763B53FCBB2</gtr:id><gtr:title>Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a2993fc77ed42ab56e9055e6aaaf4cc"><gtr:id>2a2993fc77ed42ab56e9055e6aaaf4cc</gtr:id><gtr:otherNames>Nalini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_15519_29_24139842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>643FEEEF-E0FF-4882-BF29-A8A85A8D9B20</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>54629743784bd7.47978520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E596101-6814-4E3F-AD4F-F7130173744F</gtr:id><gtr:title>Thinning of the corpus callosum and cerebellar atrophy is correlated with phenotypic severity in a family with spastic paraplegia type 11.</gtr:title><gtr:parentPublicationTitle>Journal of clinical neurology (Seoul, Korea)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1738-6586</gtr:issn><gtr:outcomeId>ihqHziKzk1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C8C18CC-5EC4-464F-BE28-105291BBF170</gtr:id><gtr:title>Author response: A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa93eeace4133.89132630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E7268B-B645-4833-B04C-93A16F684F5B</gtr:id><gtr:title>Hypersomnia with dilated pupils in adenosine monophosphate deaminase (AMPD) deficiency.</gtr:title><gtr:parentPublicationTitle>Journal of sleep research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/454302726a4f2ef471ebd89121efa41c"><gtr:id>454302726a4f2ef471ebd89121efa41c</gtr:id><gtr:otherNames>Perumal MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-1105</gtr:issn><gtr:outcomeId>pm_15519_29_24033727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D4F848F-35F0-469F-B546-3BEDB19AFDD5</gtr:id><gtr:title>A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5c596058f4e99b11d3fe3dbd4f968f"><gtr:id>5f5c596058f4e99b11d3fe3dbd4f968f</gtr:id><gtr:otherNames>Sumner CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740205172.11003535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8DB1DCD-4CB6-4759-8037-4DA079ACED06</gtr:id><gtr:title>Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec75b4974.11468102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87D2C0F5-75C5-4F05-B7A4-ECBAD35C4B4E</gtr:id><gtr:title>The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_22595371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00F8A3F1-8271-4EC3-8A9E-D7C24231D71F</gtr:id><gtr:title>Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7427df70b6faebb03dba6db478b66095"><gtr:id>7427df70b6faebb03dba6db478b66095</gtr:id><gtr:otherNames>Green P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>C5xELR8WaoN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E47BD63A-5009-4617-9196-512F42B02E77</gtr:id><gtr:title>Mutations in ? adducin are associated with inherited cerebral palsy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23836506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D967515-5D8C-466D-A5AE-E77DF7143B82</gtr:id><gtr:title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>56a4096a8a4488.71657139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CB38BFF-DA2B-49B9-8E93-E10E2506BEB5</gtr:id><gtr:title>The 4H syndrome due to RNF216 mutation.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a4096929de00.06116410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8B44EC-53BC-43A7-B2E6-CDA255FB4BEC</gtr:id><gtr:title>Gene co-expression networks shed light into diseases of brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56a409667a5ab9.40053577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE9560D-24F0-455B-9814-55B56108B845</gtr:id><gtr:title>SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec78ed4f9.39489998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3920EBC6-0747-4C21-BC64-3ED8C60B4063</gtr:id><gtr:title>A novel p.Gln175X [corrected] premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22734906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92EB3346-FA88-4128-A3C3-6D05C8789310</gtr:id><gtr:title>Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d6cd3c48df4ba250f8982f7b132101"><gtr:id>35d6cd3c48df4ba250f8982f7b132101</gtr:id><gtr:otherNames>Zimon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>UaQ9UZnr4hd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFD0B090-2EEC-4F55-AAD5-99DCB350BFAB</gtr:id><gtr:title>The clinical and genetic heterogeneity of paroxysmal dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40966a7b457.83986332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7139E24A-824B-4022-8245-C707A9CF7C74</gtr:id><gtr:title>A practical approach to diagnosing adult onset leukodystrophies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf826f577934fec360780ebfe7e1b870"><gtr:id>cf826f577934fec360780ebfe7e1b870</gtr:id><gtr:otherNames>Ahmed RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54629740ad06a5.13382899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47EC489D-82D6-4F39-BDBB-1E86ACA8BEE5</gtr:id><gtr:title>Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc4404d626048147a389c1d14ecc32"><gtr:id>fedc4404d626048147a389c1d14ecc32</gtr:id><gtr:otherNames>Bartolome F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>pm_15519_29_23498975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B742F8C-E79A-4235-A552-81574C0B3A7A</gtr:id><gtr:title>Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dda45248e47eb0023a4ccbd6908c4e"><gtr:id>a7dda45248e47eb0023a4ccbd6908c4e</gtr:id><gtr:otherNames>Thomas AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096eec8457.78218357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62D11201-27A5-49F5-824E-B9E84875CC9D</gtr:id><gtr:title>Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be4c0da55ab01c9f0e6393f9ed6fadce"><gtr:id>be4c0da55ab01c9f0e6393f9ed6fadce</gtr:id><gtr:otherNames>Hammer MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23332917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF6CFD14-5EF8-4941-BA43-C2CD975A0474</gtr:id><gtr:title>Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/673eb3a354040dbcb56dbe98ec677ebe"><gtr:id>673eb3a354040dbcb56dbe98ec677ebe</gtr:id><gtr:otherNames>van de Leemput J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>kWE8vrtQGDL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B42852C-FC98-4636-8EBB-90B94AE0F733</gtr:id><gtr:title>Mutant COQ2 in multiple-system atrophy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>54629742cf5770.72842901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95871BAA-3A2B-42E3-B207-1B32A251918B</gtr:id><gtr:title>Pathological ribonuclease H1 causes R-loop depletion and aberrant DNA segregation in mitochondria.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0868462ff4eec27e8eea7f7c7c64375"><gtr:id>d0868462ff4eec27e8eea7f7c7c64375</gtr:id><gtr:otherNames>Akman G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c7eec89425b1.30939142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADBFA836-8733-41FE-B5C5-52ED49FE8CFB</gtr:id><gtr:title>Variable phenotypes are associated with PMP22 missense mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0bc737932265eaa33cfdb00a4f429"><gtr:id>ccf0bc737932265eaa33cfdb00a4f429</gtr:id><gtr:otherNames>Russo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>mGfeoxcFU9u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06B599B3-14F8-44D9-8DD4-719B107BED4F</gtr:id><gtr:title>Reply: The p.Ser107Leu in BICD2 is a mutation 'hot spot' causing distal spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096782a918.97249459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F313FB70-07F0-4B06-A0B8-339C726FE548</gtr:id><gtr:title>Rhabdomyolysis: a genetic perspective.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>56a4096c438747.55783436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CDAE56-1E33-45FC-8FB7-5381D110674F</gtr:id><gtr:title>The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>pm_15519_29_23817214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C80977E-F240-46F6-81C4-96257DBD45AE</gtr:id><gtr:title>A Commentary on 'Four novel C20ORF54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.'.</gtr:title><gtr:parentPublicationTitle>Journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1434-5161</gtr:issn><gtr:outcomeId>pm_15519_29_22786578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>239AFDC3-C580-4892-8196-C53268C4AC43</gtr:id><gtr:title>Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22933740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5008A89-BE0B-4C40-A511-DD58B7C31F42</gtr:id><gtr:title>Sniffing out the cerebellum.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22851611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>361F6EAA-40FD-42AC-934A-89B8D2D0D67D</gtr:id><gtr:title>Severe Dejerine-Sottas disease with respiratory failure and dysmorphic features in association with a PMP22 point mutation and a 3q23 microdeletion.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ac050b4cbcf59e748973d74c7628ed4"><gtr:id>8ac050b4cbcf59e748973d74c7628ed4</gtr:id><gtr:otherNames>Voermans NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22734911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6365D678-9A3D-422C-93D0-3B5299C65762</gtr:id><gtr:title>Absence of HINT1 mutations in a UK and Spanish cohort of patients with inherited neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096997a557.19231071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C17DC94D-1153-4963-B2B9-008881AE2EA0</gtr:id><gtr:title>Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22675081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE1F1D6A-5DB5-4AB3-A836-7C38E9A70291</gtr:id><gtr:title>Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>pm_15519_29_22743658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF757FDD-4F26-4D02-973C-919A1139FFE0</gtr:id><gtr:title>The genetics and neuropathology of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_15519_29_22806825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>463A966D-B229-48AC-8EB2-280D7B6B7572</gtr:id><gtr:title>SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>58c7eec3ea7c92.48760396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C4079D7-313F-467C-94A7-454DA423550D</gtr:id><gtr:title>The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da89de5ddb6f0c22aacb38b0bac15db"><gtr:id>5da89de5ddb6f0c22aacb38b0bac15db</gtr:id><gtr:otherNames>Boizot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5462974260e7f6.86064051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19A678A1-6348-4730-B41C-881A5B9B4283</gtr:id><gtr:title>Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22297462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4588AA0E-5515-4544-BAC3-3FD367B88912</gtr:id><gtr:title>Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e6ed6a7a2b5891b2ce98ba3c5da97e2"><gtr:id>7e6ed6a7a2b5891b2ce98ba3c5da97e2</gtr:id><gtr:otherNames>Landour? G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>aqDs2LfeSZk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09479C89-2B7E-423E-99E4-30DD61AC3730</gtr:id><gtr:title>Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56a409660ec789.93763757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54748952-12F6-4D4E-B0CF-A56F581717B5</gtr:id><gtr:title>Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>pm_540e192e192422e1e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66F2865D-8E4C-4B9A-965F-8185F3CB02EC</gtr:id><gtr:title>DYT6 Dystonia: A Neuropathological Study.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>56a40967256368.30094204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9597E2E6-977C-4355-8B95-E5288F1CF76E</gtr:id><gtr:title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23077024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72B7E94B-726E-4DDD-9126-9C0FE9F5A8F6</gtr:id><gtr:title>Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974283bc23.72125321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DAB06CD-C2E0-4941-9EC0-86A73BFBB7D1</gtr:id><gtr:title>Exome sequencing in Brown-Vialetto-van Laere syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18049378950e97e3da96e50d647b5c6f"><gtr:id>18049378950e97e3da96e50d647b5c6f</gtr:id><gtr:otherNames>Johnson JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>moDWYGwR13U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>933F43F7-BEE7-4386-B103-B0ABB13E59A5</gtr:id><gtr:title>TDP-43 pathology in a patient carrying G2019S LRRK2&amp;nbsp;mutation and a novel p.Q124E MAPT.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23664753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96278B28-FDD2-4402-B566-ACDA08CF570B</gtr:id><gtr:title>Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>5462974176f2d6.36262943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1969ECBC-B262-4805-B8DF-2E87CB909270</gtr:id><gtr:title>A novel TUBB4A mutation suggests that genotype-phenotype correlation of H-ABC syndrome needs to be revisited.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096a5893b9.24399116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>439F3BA6-87E4-48FA-8D23-131A91B085CF</gtr:id><gtr:title>The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56a409684387d9.55215597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42BB8502-7DA1-471F-92D3-C80551167197</gtr:id><gtr:title>The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e905395803df499a5bf946eb9e5153e0"><gtr:id>e905395803df499a5bf946eb9e5153e0</gtr:id><gtr:otherNames>Burchell VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_15519_29_23933751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8782BCB-DCC2-47ED-8294-291A25BFCAB9</gtr:id><gtr:title>Characterisation and validation of insertions and deletions in 173 patient exomes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e624c5192e4cb8e4e04042cdb89976af"><gtr:id>e624c5192e4cb8e4e04042cdb89976af</gtr:id><gtr:otherNames>Lescai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_23251486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EFB66BC-B881-4A6B-8117-BF71906105D1</gtr:id><gtr:title>Extending the clinical spectrum of pain channelopathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22345085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB6EFBBC-49CA-4759-9198-A5F27723DEF7</gtr:id><gtr:title>LRRK2 exonic variants and risk of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d05ae276ba007db1461e7f91f861892"><gtr:id>4d05ae276ba007db1461e7f91f861892</gtr:id><gtr:otherNames>Heckman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744de35b6.66792199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14875BAE-AF4D-4ED2-AA2E-0967FC7C4B14</gtr:id><gtr:title>Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control Study.</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91630dc25534e09c426f44e546f3e65c"><gtr:id>91630dc25534e09c426f44e546f3e65c</gtr:id><gtr:otherNames>Hostettler IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>5aa93ee8329de4.53102184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B334E2D-B382-45B5-A4B2-D1800127B9F5</gtr:id><gtr:title>Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22815559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF443570-9C97-4875-9AD0-A9B035E36F37</gtr:id><gtr:title>A 6.4 Mb duplication of the a-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974332c0d5.57292373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B2094E2-AE67-42C3-B958-69EF14F95F53</gtr:id><gtr:title>Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d3a74312ac86d45efc47ac78a3c98c"><gtr:id>35d3a74312ac86d45efc47ac78a3c98c</gtr:id><gtr:otherNames>Haack TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23176820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC8A12FF-61BD-4B91-B302-C2E26E165EBF</gtr:id><gtr:title>Recent advances in bulbar syndromes: genetic causes and disease mechanisms.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>546297439f3932.11263958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33DBD29C-5924-4751-9BA9-0C169A29F2C8</gtr:id><gtr:title>Triple A syndrome: a novel compound heterozygous mutation in the AAAS gene in an Italian patient without adrenal insufficiency.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/571e28ac49e1ca773e12508dd08ba98b"><gtr:id>571e28ac49e1ca773e12508dd08ba98b</gtr:id><gtr:otherNames>Luigetti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>JDiEnuoFBp5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86D929A9-D9C4-4C3B-9612-286803B91CAD</gtr:id><gtr:title>PKD or Not PKD: That is the question.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aaa24babbcd19a7ca30f50b28b99d4e"><gtr:id>4aaa24babbcd19a7ca30f50b28b99d4e</gtr:id><gtr:otherNames>Balint B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec8edab57.96583571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5ADE9B4-32B6-4D3A-A3BD-13619F80D9E9</gtr:id><gtr:title>Kjellin syndrome: hereditary spastic paraplegia with pathognomonic macular appearance.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dab0e4563cc38ec8a53385853a2437b"><gtr:id>3dab0e4563cc38ec8a53385853a2437b</gtr:id><gtr:otherNames>Nowak VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>54629742a8e222.00852509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F92604DC-5CBB-4232-BF23-7834503868F5</gtr:id><gtr:title>Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b39d653d4d3c3376c5d341f10c040edc"><gtr:id>b39d653d4d3c3376c5d341f10c040edc</gtr:id><gtr:otherNames>Sposito T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56a40969555394.11783685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8925200-5E84-46A7-891C-CC09BD1D18F5</gtr:id><gtr:title>Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb527c8f47b11cfd2bb90849f52723e8"><gtr:id>fb527c8f47b11cfd2bb90849f52723e8</gtr:id><gtr:otherNames>McNeill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_23935950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55303C81-6E9B-4C07-A7B1-F7C00E80B772</gtr:id><gtr:title>Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea6cf7f32ce5138c0346fdb7615e95bc"><gtr:id>ea6cf7f32ce5138c0346fdb7615e95bc</gtr:id><gtr:otherNames>Polke JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>puCrTB5D7kF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7990476-B505-4274-A903-A5A1963C7DC7</gtr:id><gtr:title>Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa078abc03e0426b87406530fac025ca"><gtr:id>fa078abc03e0426b87406530fac025ca</gtr:id><gtr:otherNames>Tuschl K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c7eec57a22a8.75008271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7CE6DD70-D970-4B28-9655-43F66DD782A8</gtr:id><gtr:title>Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33fdd530dd8d5783625da53463d9f727"><gtr:id>33fdd530dd8d5783625da53463d9f727</gtr:id><gtr:otherNames>Arber CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56a4096d069932.30978528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F084168C-E003-4693-BB92-2C2B4CF2DBA9</gtr:id><gtr:title>Review: genetics and neuropathology of primary pure dystonia.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15519_29_22897341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CE80AE7-B3C6-46C9-96DA-777CBE443C1F</gtr:id><gtr:title>Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9eabd2b081856a15607eca8c8bfce6c"><gtr:id>f9eabd2b081856a15607eca8c8bfce6c</gtr:id><gtr:otherNames>Set?-Salvia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22173904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F6AD2EE-4B3B-4220-AEDE-CF4FEE6C539C</gtr:id><gtr:title>Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN/CMT type 2.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>374EC07CC76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C4F52E6-FCA5-44F8-8BBB-BDA26E5409A7</gtr:id><gtr:title>Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c476215aba277f7032e95532684d5dc"><gtr:id>0c476215aba277f7032e95532684d5dc</gtr:id><gtr:otherNames>Dusi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740d49f65.52906933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B30906D3-8958-4369-BBC2-FB33255B84C5</gtr:id><gtr:title>Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ca09ebb1473b9780612d7b5d9dafef"><gtr:id>68ca09ebb1473b9780612d7b5d9dafef</gtr:id><gtr:otherNames>Wray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_22952635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1089DA4C-B082-42D9-8F99-A14ACC45D51B</gtr:id><gtr:title>Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c5c2253c4ba1d1ab5829aa152019a46"><gtr:id>7c5c2253c4ba1d1ab5829aa152019a46</gtr:id><gtr:otherNames>Li A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15519_29_22416811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40190467-C063-42BF-803F-FA08CE9414D3</gtr:id><gtr:title>Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_15519_29_23489662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA139DA-9EB1-4489-91DD-E583E775AAAD</gtr:id><gtr:title>C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244cc363f830eda2f51ecf6bac87f6f0"><gtr:id>244cc363f830eda2f51ecf6bac87f6f0</gtr:id><gtr:otherNames>Hensman Moss DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629741286468.94539855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72C4B330-8AA1-4715-902B-39788CF34BCA</gtr:id><gtr:title>Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d52e9b420e5.71535099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD66B808-23FF-407B-B39E-5B9144BAB01C</gtr:id><gtr:title>Clinicopathologic and molecular spectrum of-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee9cf0145.41510653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3EF646C-AB64-4D78-889A-8F8BAE8C46D9</gtr:id><gtr:title>Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>56a40968d83f88.32726274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4497B35D-4A14-4B7A-8BCA-0E879098823F</gtr:id><gtr:title>Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18049378950e97e3da96e50d647b5c6f"><gtr:id>18049378950e97e3da96e50d647b5c6f</gtr:id><gtr:otherNames>Johnson JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22740598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>383D90C3-86D3-4475-9C17-C69388A4E63C</gtr:id><gtr:title>Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1707385a316c35c6294898aff4bc0ae7"><gtr:id>1707385a316c35c6294898aff4bc0ae7</gtr:id><gtr:otherNames>Oates EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23664120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6238B86E-2DA1-41B2-99C8-3FE9CA9DBAC2</gtr:id><gtr:title>Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9db8397000487616b1a525abb470315"><gtr:id>b9db8397000487616b1a525abb470315</gtr:id><gtr:otherNames>Fawcett KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22851605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD89441-28A0-4490-8177-5A91EEE18A5D</gtr:id><gtr:title>Severe axonal neuropathy is a late manifestation of SPG11.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec4819a78.36531428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFF86C33-4C61-46F3-962B-1CDD46C8006F</gtr:id><gtr:title>Common pathogenic pathways in melanoma and Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8fab38dd5065abc5a928948b76aff2f"><gtr:id>d8fab38dd5065abc5a928948b76aff2f</gtr:id><gtr:otherNames>Pais?n-Ruiz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>sNqR5jB5uch</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8391E829-313A-4236-BBC0-2FE61881968B</gtr:id><gtr:title>Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a2120c0ff4a9d24112d293975ce431d"><gtr:id>5a2120c0ff4a9d24112d293975ce431d</gtr:id><gtr:otherNames>Everett CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22893306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CFB2795-8B9C-4CAE-ADC9-24379074484C</gtr:id><gtr:title>Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec828ccf7.78367357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3FA7D64E-9800-4E98-8065-F0FA1E391D15</gtr:id><gtr:title>Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.</gtr:title><gtr:parentPublicationTitle>Rare diseases (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2167-5511</gtr:issn><gtr:outcomeId>58c7eec92aa0c7.66278096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB7F34BB-C7F8-46F4-BA15-70ED444AC2B5</gtr:id><gtr:title>Dystonic opisthotonus: a &amp;quot;red flag&amp;quot; for neurodegeneration with brain iron accumulation syndromes?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23736975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDECFAE7-CC9B-4F35-BBCC-D9690D56FA73</gtr:id><gtr:title>Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>58c7eec3353206.91987181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8FBCCF0-6724-4029-8907-AB0B702C5FC2</gtr:id><gtr:title>Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec65a8784.63257873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54F21E52-15E7-431A-86C2-A3BF85114418</gtr:id><gtr:title>Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096b19f498.12889417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3231D346-505A-44B4-B4DB-9D9B57A7C8D2</gtr:id><gtr:title>Erratum to: Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a40969bf4392.93812018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FE924CC-A1C1-46F0-B3FC-3F197DEC2407</gtr:id><gtr:title>Genome-wide estimate of the heritability of Multiple System Atrophy.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966495aa4.19373958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D89A9221-E439-4DBE-945D-0E625B7D1B2B</gtr:id><gtr:title>Genetics of neurodegenerative diseases: an overview.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e018d848f37709256b024c30ea7824c"><gtr:id>7e018d848f37709256b024c30ea7824c</gtr:id><gtr:otherNames>Pihlstr?m L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>5aa93eeb282eb9.28217907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C46AC0CF-27CE-4D62-91AB-0A2756F31754</gtr:id><gtr:title>Recent advances in the genetics of cerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>pm_15519_29_22527681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2D40F8B-057F-4287-B47A-4FEC0B6BE0D2</gtr:id><gtr:title>Homozygous mutation incausing distal vacuolar myopathy and motor neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee895cc87.61684757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD9E70DF-A3CE-4547-A86F-46D3588BCA95</gtr:id><gtr:title>Polymyositis without Beneficial Response to Steroid Therapy: Should Miyoshi Myopathy be a Differential Diagnosis?</gtr:title><gtr:parentPublicationTitle>The American journal of case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1941-5923</gtr:issn><gtr:outcomeId>58c7eec5ed6688.74304587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB370B43-3BAA-4672-A5C6-E3761144FC2F</gtr:id><gtr:title>Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096eb85313.64697040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE06BE60-34BC-45ED-8803-3FF29204844F</gtr:id><gtr:title>Genetic advances in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current opinion in rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-8711</gtr:issn><gtr:outcomeId>56a4096754e073.49998093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73169AC2-2152-4660-8FA4-E71E0CC3A22D</gtr:id><gtr:title>Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA).</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>qHtMj7wA5jQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FABDF09C-BB0D-4D7C-BFD4-1A3F24B0C07A</gtr:id><gtr:title>Clinical and genetic characterization of leukoencephalopathies in adults.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea3185d2.01438087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1118C8F0-0A1D-4926-BB84-6A6CEFF0185F</gtr:id><gtr:title>Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by a-synuclein triplication (Iowa kindred).</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c08488767bed9cf7a157d98487dc252a"><gtr:id>c08488767bed9cf7a157d98487dc252a</gtr:id><gtr:otherNames>Gwinn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>KTFp2UKQd6k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4556871C-1020-4273-977D-DD2105A233D5</gtr:id><gtr:title>PAW32 ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description of a novel kindred</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c518c76aa027ed297124266083cf43"><gtr:id>07c518c76aa027ed297124266083cf43</gtr:id><gtr:otherNames>Novak M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>kgZCK3eB5EW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F80FA491-53A8-4CC5-8461-B9A30D977627</gtr:id><gtr:title>VPS13C-Another Hint at Mitochondrial Dysfunction in Familial Parkinson's Disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2de2cd48d9052ac53c03db9958be261"><gtr:id>f2de2cd48d9052ac53c03db9958be261</gtr:id><gtr:otherNames>Schreglmann SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4daa478.57365655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>793C7BB5-2C39-428D-92B2-AC5CC710E87F</gtr:id><gtr:title>A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: A 30-year diagnostic delay caused by misleading biochemical findings.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a40969f26c91.18516731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADE7148-B21B-4472-A8D8-1C062D064A16</gtr:id><gtr:title>The neuropathology, pathophysiology and genetics of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699401602f933276abda64770fc6df19"><gtr:id>699401602f933276abda64770fc6df19</gtr:id><gtr:otherNames>Ahmed Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>RY4bhnURF54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F92B9FF7-9D59-4B24-918F-91BAF9FB190C</gtr:id><gtr:title>Call for participation in the neurogenetics consortium within the Human Variome Project.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf0a954d1d5828f1ecd056a80ce34553"><gtr:id>cf0a954d1d5828f1ecd056a80ce34553</gtr:id><gtr:otherNames>Haworth A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>UijPrNfkLdo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F29A0DF8-1306-4345-81E7-523D776C73F8</gtr:id><gtr:title>ADCY5 mutations are another cause of benign hereditary chorea.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56a4096ab9d4d9.60646755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7C07C06-6828-4474-99D4-ABFD4FF019ED</gtr:id><gtr:title>Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4de2a860f153838d0613290971dc2033"><gtr:id>4de2a860f153838d0613290971dc2033</gtr:id><gtr:otherNames>Ernst D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>56a4096d69b521.57465978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F88CEDD4-DB15-45FB-BC2A-A4602DAA0E38</gtr:id><gtr:title>Novel single base-pair deletion in exon 1 of XK gene leading to McLeod syndrome with chorea, muscle wasting, peripheral neuropathy, acanthocytosis and haemolysis.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>546297419ac958.95671858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42341199-BA9E-4F6B-AB72-A3E3B8352387</gtr:id><gtr:title>Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8fab38dd5065abc5a928948b76aff2f"><gtr:id>d8fab38dd5065abc5a928948b76aff2f</gtr:id><gtr:otherNames>Pais?n-Ruiz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_20619503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BA973E7-A1F5-4016-AE90-F57C9AAC1ED4</gtr:id><gtr:title>Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>pm_15519_29_22765307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>791C732D-B257-4D3E-A2D5-DC830AD920FE</gtr:id><gtr:title>PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/008714e03cc79922a19d3b457141b891"><gtr:id>008714e03cc79922a19d3b457141b891</gtr:id><gtr:otherNames>Zollo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea7a5a71.22024713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE1B8673-2D68-4EC9-BEB8-45FE52CDAEC4</gtr:id><gtr:title>Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4fe90f775f7ad2b26d983c719e78eb"><gtr:id>bd4fe90f775f7ad2b26d983c719e78eb</gtr:id><gtr:otherNames>Davidson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22302274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AC4A8FC-3C67-4FEA-B97B-EFCA2B5F9216</gtr:id><gtr:title>Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096f2b9fa4.77241995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DC4C0B1-289C-4130-AC79-8678FCBDD677</gtr:id><gtr:title>Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c7eec952ad95.18955916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8145AFCD-44CD-4CDE-86E0-B9E9C2A53D2E</gtr:id><gtr:title>Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e8073c0bd0f69cf5756d64d9d62fcdc"><gtr:id>8e8073c0bd0f69cf5756d64d9d62fcdc</gtr:id><gtr:otherNames>Alg VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23733552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>109E0C27-EEE0-4E7C-879E-6FBB5B8012F9</gtr:id><gtr:title>Triple trouble: a striking new phenotype or competing genes in a family with hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec9b92e09.73733099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AEA538D-4E9B-4561-9AD1-1D23E5133824</gtr:id><gtr:title>Indian-subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/286ad8dd6acb6dc065094f60ddb9d0d5"><gtr:id>286ad8dd6acb6dc065094f60ddb9d0d5</gtr:id><gtr:otherNames>Aggarwal A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>XTWphzZfu2X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3382DA7-829D-41BC-87AB-0431C91C2175</gtr:id><gtr:title>De novo KCNA2 mutations cause hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec2cc5450.84221112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9187DF34-4D07-4991-B9B0-E22A4CD8C87D</gtr:id><gtr:title>a-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_15519_29_23404372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>775BB5F3-DEB5-47F5-940B-886A3DB9E8B7</gtr:id><gtr:title>A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>Y1uWFcVoWXt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7B8824F-B01A-45A1-BEAB-000FBB7EA9BE</gtr:id><gtr:title>Exome sequencing uncovers hidden pathways in familial and sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56a4096ca51bc1.18740967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09411975-ECE3-4AE2-B784-DEDDD4F0C3C2</gtr:id><gtr:title>Ongoing developments in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current rheumatology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/973fa2ad4c5615dcdcf432bf2cfb16da"><gtr:id>973fa2ad4c5615dcdcf432bf2cfb16da</gtr:id><gtr:otherNames>Machado PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-3774</gtr:issn><gtr:outcomeId>56a4096e869015.28963566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11A1A1CB-C4DC-4502-8308-2FC31EB051D0</gtr:id><gtr:title>Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974355cc11.45350617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC944318-2CD8-4820-B530-B7C9BD228D56</gtr:id><gtr:title>Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23881105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9477A8EB-A598-4AD6-8219-45B0C70705F4</gtr:id><gtr:title>High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_22445326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2412BEF8-2F91-47CA-A1AD-0317E5EE20B9</gtr:id><gtr:title>A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3448b53cd01a1b60a66c2f94ca21c3"><gtr:id>9f3448b53cd01a1b60a66c2f94ca21c3</gtr:id><gtr:otherNames>Khaleeli Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096bdee9e2.31970876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A7C291-C860-4397-8262-770899A1A3FD</gtr:id><gtr:title>Redefining the phenotype of ALSP andmutation-related leukodystrophy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72581e71106155fae7679c5a668017b5"><gtr:id>72581e71106155fae7679c5a668017b5</gtr:id><gtr:otherNames>Lakshmanan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec299cae4.20362245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A74614-4B05-41BE-BDF9-FA0461516546</gtr:id><gtr:title>Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744764488.38556794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BC2F355-7A0D-4129-B8DA-ADFAAC033357</gtr:id><gtr:title>Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>56a4096b4492b0.58495591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC9AF1D0-F77D-4B25-B105-4ED9512DACE7</gtr:id><gtr:title>Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096a280c82.49246620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>742FA7FC-D706-4122-8A5D-129304CBECD7</gtr:id><gtr:title>Towards a complete resolution of the genetic architecture of disease.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3da33927ae0fe73df3e7c6f9ee690b42"><gtr:id>3da33927ae0fe73df3e7c6f9ee690b42</gtr:id><gtr:otherNames>Singleton AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>bQ1jQCSUqZD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BCF113B-52DB-402B-84DE-8970E35A1F8D</gtr:id><gtr:title>?-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15207479c0ab3461d4182e7e05fa69ea"><gtr:id>15207479c0ab3461d4182e7e05fa69ea</gtr:id><gtr:otherNames>Hayflick SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23687123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52C0DEC4-3081-412F-96AE-BB1A935AE978</gtr:id><gtr:title>a-Synuclein mutations cluster around a putative protein loop.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>pm_15519_29_23669636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE715F8A-D426-4FE1-93FC-2B9B5354382F</gtr:id><gtr:title>An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44b9220f49dff6ea9205d964cd07638a"><gtr:id>44b9220f49dff6ea9205d964cd07638a</gtr:id><gtr:otherNames>Novak MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>VBDyN1FVYQs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAB4DC9E-6220-4E9A-AEA6-280B569CED51</gtr:id><gtr:title>HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis and related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c05a2a09474056b5d5c18a55d9bd46c8"><gtr:id>c05a2a09474056b5d5c18a55d9bd46c8</gtr:id><gtr:otherNames>Yaldizli ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2211-0348</gtr:issn><gtr:outcomeId>58c7eec9e88021.71288858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3DC6DD8-101B-4894-938F-8AA7033D5B1F</gtr:id><gtr:title>KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d631037f5320d11a281f3a0b1b2d319"><gtr:id>5d631037f5320d11a281f3a0b1b2d319</gtr:id><gtr:otherNames>Rivi?re JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>qYoXnb2jbYh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56BDB906-7DB5-40EC-9DDB-A320A3535573</gtr:id><gtr:title>The phenotypic spectrum of DYT24 due to ANO3 mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>54629741509c27.07505633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>684E9886-254B-47DC-8D6A-2A10F8BC4EA1</gtr:id><gtr:title>Defects of RNA metabolism in the pathogenesis of spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4d0f80718b51ee04d0d4b40400c130"><gtr:id>bd4d0f80718b51ee04d0d4b40400c130</gtr:id><gtr:otherNames>Bertini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974213b6c9.14520346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>409E97B4-AD79-4059-B7A7-BBC5E5468D91</gtr:id><gtr:title>Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ca917b7a90a50ab88287e6b9367286"><gtr:id>f7ca917b7a90a50ab88287e6b9367286</gtr:id><gtr:otherNames>Ramos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>56a40968a53572.88065710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D8D6BCC-AB24-43E2-8584-A60BC7E41018</gtr:id><gtr:title>Assessment of Parkinson's disease risk loci in Greece.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_24080174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA917795-9EC8-4602-9949-E4295EE9368E</gtr:id><gtr:title>The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675dfa36250f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6D272C8-09AD-4B44-A269-DC9F19F5CFFD</gtr:id><gtr:title>Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297442a8b88.32062614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A340CF4C-4060-4A17-8675-79F6FA241F96</gtr:id><gtr:title>Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/504251fb9f77e909097edc11a8ec2e6f"><gtr:id>504251fb9f77e909097edc11a8ec2e6f</gtr:id><gtr:otherNames>Penno A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>Jns2ZXgrzzn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE01F49-9F10-4D25-9CBF-E1B712E4AC1C</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5462974302d6a4.17325265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C2701D9-985C-4045-BC97-252D63F30C41</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1058A607-47B2-46E9-B4BE-F11399535ADF</gtr:id><gtr:title>Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c984efdac34b58497e7b0f51d6d10eb"><gtr:id>0c984efdac34b58497e7b0f51d6d10eb</gtr:id><gtr:otherNames>Meyer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c7eec300d1e8.51172808</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802760</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>